Anesthetic management and outcomes for patients with pulmonary hypertension and intracardiac shunts and Eisenmenger syndrome: a review of institutional experience

被引:46
作者
Bennett, Jeremy M. [1 ]
Ehrenfeld, Jesse M. [1 ]
Markham, Larry [2 ]
Eagle, Susan S. [1 ]
机构
[1] Vanderbilt Univ, Med Ctr, Dept Cardiothorac Anesthesiol, Nashville, TN 37232 USA
[2] Vanderbilt Univ, Med Ctr, Dept Med, Div Cardiol, Nashville, TN 37232 USA
关键词
Congenital heart disease; Eisenmenger syndrome; Etomidate; Hypotension; Monitored anesthesia care; Vasopressors; CONGENITAL HEART-DISEASE; ARTERIAL-HYPERTENSION; NONCARDIAC SURGERY; NITRIC-OXIDE; ADULTS;
D O I
10.1016/j.jclinane.2013.11.022
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Study Objective: To propose a set of recommendations for the perioperative management of patients with Eisenmenger syndrome and similar physiology, based on 20 years of experience at a single institution. Design: Retrospective study of institutional outcomes of Eisenmenger syndrome patients, and patients with balanced or fixed right-to-left intracardiac shunts with pulmonary hypertension undergoing noncardiac surgery. Setting: Single center, university-affiliated hospital. Measurements: Measurements included data from patients with Eisenmenger syndrome or similar physiology, shunt direction, right ventricular systolic pressure, congestive heart failure classification, noncardiac surgery, type of anesthesia, echocardiographic and catheterization data, mortality within 30 days of surgery, choice of monitoring, and vasopressor use. Main Results: 33 patients with Eisenmenger syndrome or similar physiology undergoing 53 general, regional and/or monitored anesthetic procedures were identified. Significant systemic arterial hypotension occurred in 14 individuals (26%) and oxygen desaturation in 9 (17%) patients. Administration of an intravenous (IV) vasopressor agent during induction significantly decreased the incidence of hypotension. The type of IV induction agent did not influence hemodynamic alterations, though patients who received propofol experienced a trend towards increased hypotension (83% of pts) when a vasopressor was not used. Inhalational induction, regardless of vasopressor use, was more likely to result in hypotension (60% of pts). The 30-day mortality was 3.8% (two pts). Both patients had minor elective procedures with monitored anesthesia care (MAC). Conclusions: Hypotension is more common in patients with Eisenmenger syndrome and similar physiology when a vasopressor is not used during the pen-induction period, regardless of induction agent. Etomidate tended to have better hemodynamic stability than other induction agents. The use of a vasopressor is recommended. We present general recommendations for anesthesiologists and strongly recommend use of a vasopressor before or during induction to reduce hypotension along with complete avoidance of inhalational induction. Further, MAC anesthesia has been associated with perioperative and 30-day mortality. (C) 2014 Elsevier Inc. All rights reserved.
引用
收藏
页码:286 / 293
页数:8
相关论文
共 19 条
[1]   Noncardiac surgery in Eisenmenger syndrome [J].
Ammash, NM ;
Connolly, HM ;
Abel, MD ;
Warnes, CA .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1999, 33 (01) :222-227
[2]   ANESTHETIC IMPLICATIONS OF ADULTS WITH CONGENITAL HEART-DISEASE [J].
BAUM, VC ;
PERLOFF, JK .
ANESTHESIA AND ANALGESIA, 1993, 76 (06) :1342-1358
[3]   Evidence-based Pharmacologic management of pulmonary arterial hypertension [J].
Benedict, Neal ;
Seybert, Amy ;
Mathier, Michael A. .
CLINICAL THERAPEUTICS, 2007, 29 (10) :2134-2153
[4]   Peri-operative trans-oesophageal echo cardiography and nitric oxide during general anaesthesia in a patient with Eisenmenger's syndrome [J].
Bouch, D. C. ;
Allsager, C. M. ;
Moore, N. .
ANAESTHESIA, 2006, 61 (10) :996-1000
[5]   Residual pulmonary vasoreactivity to inhaled nitric oxide in patients with severe obstructive pulmonary hypertension and Eisenmenger syndrome [J].
Budts, W ;
Van Pelt, N ;
Gillyns, H ;
Gewillig, M ;
van de Werf, F ;
Janssens, S .
HEART, 2001, 86 (05) :553-558
[6]   Eisenmenger syndrome - Factors relating to deterioration and death [J].
Daliento, L ;
Somerville, J ;
Presbitero, P ;
Menti, L ;
Brach-Prevert, S ;
Rizzoli, G ;
Stone, S .
EUROPEAN HEART JOURNAL, 1998, 19 (12) :1845-1855
[7]   Caring for adults with congenital cardiac disease: successes and challenges for 2007 and beyond [J].
Dearani, Joseph A. ;
Connolly, Heidi M. ;
Martinez, Richard ;
Fontanet, Hector ;
Webb, Gary D. .
CARDIOLOGY IN THE YOUNG, 2007, 17 :87-96
[8]  
FOSTER JMG, 1984, ANN ROY COLL SURG, V66, P353
[9]   Management of pulmonary arterial hypertension associated with congenital systemic-to-pulmonary shunts and Eisenmenger's syndrome [J].
Galie, Nazzareno ;
Manes, Alessandra ;
Palazzini, Massimiliano ;
Negro, Luca ;
Marinelli, Alessandro ;
Gambetti, Simona ;
Mariucci, Elisabetta ;
Donti, Andrea ;
Branzi, Angelo ;
Picchio, Fernando M. .
DRUGS, 2008, 68 (08) :1049-1066
[10]   Anaesthetic implications of grown-up congenital heart disease [J].
Lovell, AT .
BRITISH JOURNAL OF ANAESTHESIA, 2004, 93 (01) :129-139